WeedWired

Legal Cannabis Business News and Views

Home / Marijuana Legalization / National Institute on Drug Abuse Director Shows Support for Expanding CBD Research

National Institute on Drug Abuse Director Shows Support for Expanding CBD Research

August 27, 2015

cannabis-backgroundThe director of the National Institute on Drug Abuse, Nora Volkow, recently showed support for redoubling research efforts on cannabis. She particularly wants further research done on cannabidiol (CDB) and its therapeutic effects.

Volkow feels that CBD may yet have a range of medicinal uses that we have yet to discover, such as how it can help with seizures and neurological disorders. She goes as far as to say, “In the impassioned, often emotional debates these days over medical marijuana, CBD is often cited as one of the main reasons restrictions on marijuana should be loosened.”

There has been plenty of research completed on CBD already, but scientists have only just dipped a toe in the pool. Of the research collected, we do know that CBD can have a major effect on epilepsy and multiple sclerosis (MS). Moreover, scientists have recently discovered that CBD can play a part in speeding up bone fracture recovery rates.

Using CBD for medicinal purposes is far from a new concept; although, it was brought “back into fashion” two years ago after a CNN piece by Dr. Sanjay Gupta discussing medical cannabis.

Since the 1970s, scientists have known the potential use of CBD for seizure patients. In the 70s, there were a few (positive) small trials run on epileptic adults; however, the potential to help epileptic children is the true driving force behind the need for additional CBD research.

By speaking out in favor of CBD research, Volkow hopes research forays can increase quickly and that patients in need can receive treatment from CBD.

Speaking with conviction, Volkow states, “Parents can’t wait — their children are growing; their children’s brains are actively developing; and the repeated seizures may be damaging this growth. Parents currently must navigate states’ medical marijuana laws or defy the law to obtain CBD extracts — which, in the current unregulated market, may be of questionable quality and content.”

Read more about this story here.

Filed Under: Marijuana Legalization Tagged With: cannabidiol, legalization, medicinal cannabis, research

Strain Library

WeedWired’s Cannabis Strain Guide

Strain Library

Categories

  • Cannabidiol (CBD)
  • Industry News
  • Marijuana Legalization
  • Medical Marijuana
  • Strain Library

Recent Posts

  • Majority of US Voters in Favor of Marijuana Legalization
  • Baltimore Ravens Monroe Working to Start a Dialogue about Cannabis in NFL
  • California Works Toward Having Recreational Marijuana on November’s Ballot
  • College Football Conferences Should Unify Marijuana Policies
  • The Latest Research on Pregnancy and Cannabis Use

Latest & Greatest

  • Canna Sensation
  • 420 Singles
  • Marijuana Policy Project
  • High Times
  • Leafly

CBD Pure Organic
Pain Relief Oil

CBD Oil for
Dogs & Cats

 

RSS Around the Web

  • Minnesota Marijuana Legalization Bill Advances Through Fourth House Committee And ... January 27, 2023
  • Proposed Ohio bill would relax OVI rules for marijuana users - WEWS January 27, 2023
  • Georgia agency approves rules for medical marijuana sales - Big Rapids Pioneer January 27, 2023
  • More votes are required before medical marijuana dispensaries open in Georgia January 27, 2023
  • Curaleaf winds down cannabis ops in California, Colorado and Oregon January 27, 2023

© 2023 WeedWired. All rights reserved.